Search research articles
Contact Us
Filters
Showing results (431-440 of 583) with videos related to
Page
of 59
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2004
Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461
Guido Marcucci, Krzysztof Mrózek, Amy S Ruppert, et al.
Blood
|
December 11, 2012
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway
Yonghui Li, Li Gao, Xufeng Luo, et al.
Blood
|
February 15, 1996
Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia
M R Baer, S H Bernstein, V L Brunetto, et al.
Leukemia
|
May 29, 2020
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years
Ann-Kathrin Eisfeld, Jessica Kohlschmidt, Alice Mims, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461
J C Byrd, R B Weiss, D C Arthur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2004
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621
Jonathan E Kolitz, Stephen L George, Richard K Dodge, et al.
Leukemia
|
October 10, 2015
UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO
S Goyama, J Schibler, A Gasilina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2004
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461
John C Byrd, Amy S Ruppert, Krzysztof Mrózek, et al.
Blood
|
May 26, 1999
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience
M Wetzler, R K Dodge, K Mrózek, et al.
American Journal of Hematology
|
January 31, 2017
Prognostic impact of the CD34+/CD38- cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation
Madlen Jentzsch, Marius Bill, Deedra Nicolet, et al.
Page
of 59
Search research articles
Search
Showing results (431-440 of 583) with videos related to
Sort By:
Page
of 59
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2004
Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461
Guido Marcucci, Krzysztof Mrózek, Amy S Ruppert, et al.
Blood
|
December 11, 2012
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway
Yonghui Li, Li Gao, Xufeng Luo, et al.
Blood
|
February 15, 1996
Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia
M R Baer, S H Bernstein, V L Brunetto, et al.
Leukemia
|
May 29, 2020
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years
Ann-Kathrin Eisfeld, Jessica Kohlschmidt, Alice Mims, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461
J C Byrd, R B Weiss, D C Arthur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2004
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621
Jonathan E Kolitz, Stephen L George, Richard K Dodge, et al.
Leukemia
|
October 10, 2015
UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO
S Goyama, J Schibler, A Gasilina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2004
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461
John C Byrd, Amy S Ruppert, Krzysztof Mrózek, et al.
Blood
|
May 26, 1999
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience
M Wetzler, R K Dodge, K Mrózek, et al.
American Journal of Hematology
|
January 31, 2017
Prognostic impact of the CD34+/CD38- cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation
Madlen Jentzsch, Marius Bill, Deedra Nicolet, et al.
Page
of 59